Mesa Laboratories (MLI) Stock Statistics & Valuation Metrics
Total Valuation
Mesa Laboratories has a market cap or net worth of EUR 638.25M. The enterprise value is EUR 703.77M.
- Market Cap
- EUR 638.25M
- Enterprise Value
- EUR 703.77M
Share Statistics
Mesa Laboratories has 5,595,869 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 5,595,869
- Owned by Insiders
- 3.69%
- Owned by Institutions
- 46.23%
Financial Efficiency
Mesa Laboratories’s return on equity (ROE) is 0.04 and return on invested capital (ROIC) is 2.76%.
- Return on Equity (ROE)
- 0.04
- Return on Assets (ROA)
- 0.02
- Return on Invested Capital (ROIC)
- 2.76%
- Return on Capital Employed (ROCE)
- 0.05
- Revenue Per Employee
- 347.46K
- Profits Per Employee
- 9,361.227
- Employee Count
- 717
- Asset Turnover
- 0.58
- Inventory Turnover
- 3.45
Valuation Ratios
The current PE Ratio of Mesa Laboratories is 148.62. Mesa Laboratories’s PEG ratio is -0.40.
- PE Ratio
- 148.62
- PS Ratio
- 2.86
- PB Ratio
- 3.83
- Price to FCF
- 12.74
- Price to Operating Cash Flow
- 12.99
- PEG Ratio
- -0.40
Income Statement
In the last 12 months, Mesa Laboratories had revenue of 249.13M and earned 6.71M in profits. Earnings per share was 1.22.
- Revenue
- 249.13M
- Gross Profit
- 158.27M
- Operating Income
- 18.51M
- Pretax Income
- 12.01M
- Net Income
- 6.71M
- EBITDA
- 35.28M
- Earnings Per Share (EPS)
- 1.22
Cash Flow
In the last 12 months, operating cash flow was 55.67M and capital expenditures 450,000, giving a free cash flow of 56.12M billion.
- Operating Cash Flow
- 55.67M
- Free Cash Flow
- 56.12M
- Free Cash Flow per Share
- 9.92
Dividends & Yields
Mesa Laboratories pays an annual dividend of ―, resulting in a dividend yield of 0.47%
- Dividend Per Share
- ―
- Dividend Yield
- 0.47%
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 7.85%
- Earnings Yield
- 0.66%
Stock Price Statistics
- Beta
- 0.88
- 52-Week Price Change
- 81.54%
- 50-Day Moving Average
- 111.10
- 200-Day Moving Average
- 88.96
- Relative Strength Index (RSI)
- 59.69
- Average Volume (3m)
- 323
Important Dates
Mesa Laboratories upcoming earnings date is Nov 09, 2026, After Close (Not Confirmed).
- Last Earnings Date
- Aug 10, 2026
- Next Earnings Date
- Nov 09, 2026
- Ex-Dividend Date
- ―
Financial Position
Mesa Laboratories as a current ratio of 1.72, with Debt / Equity ratio of 90.65%
- Current Ratio
- 1.72
- Quick Ratio
- 1.29
- Debt to Market Cap
- 0.31
- Net Debt to EBITDA
- 4.02
- Interest Coverage Ratio
- 1.73
Taxes
In the past 12 months, Mesa Laboratories has paid 5.30M in taxes.
- Income Tax
- 5.30M
- Effective Tax Rate
- 0.44
Enterprise Valuation
Mesa Laboratories EV to EBITDA ratio is 19.37, with an EV/FCF ratio of 14.00.
- EV to Sales
- 3.15
- EV to EBITDA
- 19.37
- EV to Free Cash Flow
- 14.00
- EV to Operating Cash Flow
- 14.12
Balance Sheet
Mesa Laboratories has EUR 30.70M in cash and marketable securities with EUR 101.36M in debt, giving a net cash position of -EUR 70.66M billion.
- Cash & Marketable Securities
- EUR 30.70M
- Total Debt
- EUR 101.36M
- Net Cash
- -EUR 70.66M
- Net Cash Per Share
- -EUR 12.63
- Tangible Book Value Per Share
- -EUR 13.38
Margins
Gross margin is 65.99%, with operating margin of 9.00%, and net profit margin of 1.92%.
- Gross Margin
- 65.99%
- Operating Margin
- 9.00%
- Pretax Margin
- 3.75%
- Net Profit Margin
- 1.92%
- EBITDA Margin
- 16.25%
- EBIT Margin
- 7.05%
Analyst Forecast
The average price target for Mesa Laboratories is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- -4.04%
- EPS Growth Forecast
- ―
Scores
- Smart Score
- 5
- AI Score
- ―